|

Mid-day market update: Stocks extend losses, Dow tumbles over 400 points

U.S. stocks extended its earlier losses midway through trading on Tuesday, amid rising tensions between Russia and Ukraine. Russian President Vladimir Putin said he would recognize the independence of two Russian-led breakaway regions of Ukraine and ordered Russian troops to go into eastern Ukraine.

The Dow traded down 1.31% to 33,631.65 while the NASDAQ fell 1.42% to 13,356.05. The S&P also fell, dropping, 1.08% to 4,301.81.

Leading and Lagging Sectors

Utilities shares slipped by just 0.1% on Tuesday. Meanwhile, top gainers in the sector included Empresa Distribuidora y Comercializadora Norte Sociedad Anónima EDN +6.73% (Get Free Alerts for EDN), up 7% and Companhia de Saneamento Básico do Estado de São Paulo - SABESP SBS +6.35% up 7%.

In trading on Tuesday, consumer discretionary shares tumbled by 3.3%.

Top Headline

Home Depot Inc HD -9.55% reported better-than-expected earnings for its fourth quarter and raised its dividend.

Home Depot reported fourth-quarter FY21 sales growth of 10.7% year-on-year, to $35.72 billion, beating the analyst consensus of $34.87 billion. EPS of $3.21 beat the analyst consensus of $3.17.

Home Depot raised the quarterly dividend by 15% to $1.90 from $1.65 per share, payable on March 24, 2022, to shareholders of record on the close of business on March 10, 2022.

The company expects FY22 EPS growth to be in the low single digits. Home Depot sees FY22 sales and comparable sales growth to be slightly positive.

Equities Trading UP

Meritor, Inc. MTOR +44.95% shares shot up 45% to $35.81. Cummins Inc CMI -1.69% agreed to acquire electric powertrain solutions provider Meritor for about $3.7 billion, including assumed debt and net of acquired cash.

Shares of Indonesia Energy Corporation Limited INDO +64.37% got a boost, shooting 58% to $7.09.

Ocugen, Inc. OCGN +24.27% shares were also up, gaining 29% to $4.46 after the company announced the FDA lifted its clinical hold on the company's COVID-19 vaccine study in the US.

Equities Trading DOWN

Allarity Therapeutics, Inc. ALLR -31.03% shares tumbled 31% to $4.5750. The FDA provided Allarity Therapeutics with a Refusal to File (RTF) letter for a marketing application for dovitinib for the third-line treatment of metastatic renal cell carcinoma (mRCC).

Shares of Dogness (International) Corporation DOGZ -40.98% were down 40% to $2.55 after the company reported entry into agreement for registered direct offering of approximately $5.66 million of class A common shares.

Homology Medicines, Inc. FIXX -31.22% was down, falling 31% to $2.6601. The FDA placed a clinical hold on Homology Medicines’ pheNIX gene therapy trial of HMI-102 from the FDA. An official clinical hold letter is expected within 30 days.

Commodities

In commodity news, oil traded up 2.1% to $93.00, while gold traded up 0.3% to $1,905.10.

Silver traded up 1.2% Tuesday to $24.275 while copper fell 0.1% to $4.5085.

Euro zone

European shares were mixed today. The eurozone’s STOXX 600 gained 0.07%, London’s FTSE 100 rose 0.13%, while Spain’s IBEX 35 Index rose 0.05%. The German DAX fell 0.26%, French CAC 40 slipped 0.01% and Italy’s FTSE MIB Index fell 0.02%.

The UK government reported a £2.9 billion surplus in its public finances in January, versus a £2.5 billion deficit a year ago. The Ifo Business Climate indicator for Germany climbed to 98.9 in February from a revised level of 96 in January. The annual inflation rate in Italy increased to 4.8% in January from 3.9% in the earlier month.

Economics

The S&P CoreLogic Case-Shiller home price index surged 18.6% year-over-year in December.

The FHFA House Price Index rose 1.2% from a month ago in December.

The IHS Markit manufacturing PMI rose to 57.5 in February from 55.5 in the previous month, while services PMI climbed to 56.7 from 51.2.

The Conference Board’s consumer confidence index fell to 110.5 in February from previous reading of 111.1.

Federal Reserve Bank of Atlanta President Raphael Bostic is set to speak at 3:30 p.m. ET.

Author

Benzinga Team

Benzinga's news desk is a dynamic and innovative team that provides real-time, actionable articles that help readers navigate the market.

More from Benzinga Team
Share:

Editor's Picks

EUR/USD flirts with daily highs, retargets 1.1900

EUR/USD regains upside traction, returning to the 1.1880 zone and refocusing its attention to the key 1.1900 barrier. The pair’s slight gains comes against the backdrop of a humble decline in the US Dollar as investors continue to assess the latest US CPI readings and the potential Fed’s rate path.

GBP/USD remains well bid around 1.3650

GBP/USD maintains its upside momentum in place, hovering around daily highs near 1.3650 and setting aside part of the recent three-day drop. Cable’s improved sentiment comes on the back of the Greenback’s  irresolute price action, while recent hawkish comments from the BoE’s Pill also collaborate with the uptick.

Gold clings to gains just above $5,000/oz

Gold is reclaiming part of the ground lost on Wednesday’s marked decline, as bargain-hunters keep piling up and lifting prices past the key $5,000 per troy ounce. The precious metal’s move higher is also underpinned by the slight pullback in the US Dollar and declining US Treasury yields across the curve.

Crypto Today: Bitcoin, Ethereum, XRP in choppy price action, weighed down by falling institutional interest 

Bitcoin's upside remains largely constrained amid weak technicals and declining institutional interest. Ethereum trades sideways above $1,900 support with the upside capped below $2,000 amid ETF outflows.

Week ahead – Data blitz, Fed Minutes and RBNZ decision in the spotlight

US GDP and PCE inflation are main highlights, plus the Fed minutes. UK and Japan have busy calendars too with focus on CPI. Flash PMIs for February will also be doing the rounds. RBNZ meets, is unlikely to follow RBA’s hawkish path.

Ripple Price Forecast: XRP potential bottom could be in sight

Ripple edges up above the intraday low of $1.35 at the time of writing on Friday amid mixed price actions across the crypto market. The remittance token failed to hold support at $1.40 the previous day, reflecting risk-off sentiment amid a decline in retail and institutional sentiment.